Senator Christopher Cabaldon (D-Yolo) announced Senate District Three’s 2025 Woman of the Year — Carol Whichard, who was recognized for her tireless efforts advocating for working families, standing ...

Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes, today announced that it has dosed the first patient in the ...

Researchers at Kumamoto University have successfully executed a practical trial of a new genome-editing technique that allows ...

A human-specific NOVA1 variant changed mouse vocalizations, potentially providing insights into the evolution of language.

Plants survive cold by adjusting at cellular level. Scientists discovered that the PORCUPINE protein helps plants adapt to ...

As climate conditions become increasingly unpredictable, understanding how plants respond to cold is crucial for securing ...

Ribopeutic Inc. has divulged nucleic acid splicing modulators (particularly, Huntingtin [HTT; HD] [mutant] and/or transcriptional activator Myb [c-Myb]) reported to be useful for the treatment of ...

Spliceosome structures have been investigated extensively in the past decade, but most of the studies have been restricted to ...

RNA sequencing has emerged as a powerful supplement to DNA sequencing for Mendelian disease diagnosis, but clinical ...

RNA sequencing has emerged as a powerful supplement to DNA sequencing for Mendelian disease diagnosis, but clinical ...